In Treatment of Respiratory tract infection Azyxin Plus 250 mg/75 mg Tablet helps treat respiratory tract infection by killing the bacteria causing infection. It also helps to loosen thick mucus, making it easier to cough out. This reduces congestion or stuffiness and helps in easy breathing. This medicine usually starts to work within a few minutes and the effects can last up to several hours. Along with medications, drink enough lukewarm water and gargle with warm salt water to feel better.
It is unsafe to consume alcohol with Azyxin Plus 250 mg/75 mg Tablet.
Azyxin Plus 250 mg/75 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Azyxin Plus 250 mg/75 mg Tablet during breastfeeding is not available. Please consult your doctor.
It is not known whether Azyxin Plus 250 mg/75 mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Azyxin Plus 250 mg/75 mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Azyxin Plus 250 mg/75 mg Tablet may be needed. Please consult your doctor.
Azyxin Plus 250 mg/75 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Azyxin Plus 250 mg/75 mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Azyxin Plus 250 mg/75 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Alembic Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)